Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

[Influence factors on the formation of mammospheres from breast cancer stem cells].

Huang MZ, Zhang FC, Zhang YY.

Beijing Da Xue Xue Bao Yi Xue Ban. 2008 Oct 18;40(5):500-4. Chinese.

2.

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.

Phillips TM, McBride WH, Pajonk F.

J Natl Cancer Inst. 2006 Dec 20;98(24):1777-85.

PMID:
17179479
3.

Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression.

Zhang F, Song C, Ma Y, Tang L, Xu Y, Wang H.

Int J Mol Med. 2011 Sep;28(3):365-71. doi: 10.3892/ijmm.2011.700. Epub 2011 May 13.

PMID:
21573501
4.

[Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].

Peng L, Li FX, Shao WF, Xiong JB.

Nan Fang Yi Ke Da Xue Xue Bao. 2013 Oct;33(10):1421-6. Chinese.

5.

[Dendritic cells infected by recombinant adeno-associated virus with CEA gene to induce antigen-specific CTL response to CD44(+)CD24(-/low) cells from MCF-7 breast cancer cell line].

Wang XL, Ma B, Jia J, Yuan YH, Yan Y, Di LJ, Song GH, Yu J, Ren J.

Beijing Da Xue Xue Bao Yi Xue Ban. 2011 Apr 18;43(2):173-8. Chinese.

6.

[Detection of breast cancer stem cells and the expression of key molecules in Hedgehog signaling pathway].

Lu ZH, Jia J, Ren J, Ma B, DI LJ, Song GH.

Beijing Da Xue Xue Bao Yi Xue Ban. 2008 Oct 18;40(5):480-5. Chinese.

7.

CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.

Ji P, Zhang Y, Wang SJ, Ge HL, Zhao GP, Xu YC, Wang Y.

Oncol Rep. 2016 Jun;35(6):3293-302. doi: 10.3892/or.2016.4739. Epub 2016 Apr 11.

PMID:
27109463
8.

Comparison of mammosphere formation from breast cancer cell lines and primary breast tumors.

Wang R, Lv Q, Meng W, Tan Q, Zhang S, Mo X, Yang X.

J Thorac Dis. 2014 Jun;6(6):829-37. doi: 10.3978/j.issn.2072-1439.2014.03.38.

9.

Senescence evasion by MCF-7 human breast tumor-initiating cells.

Karimi-Busheri F, Rasouli-Nia A, Mackey JR, Weinfeld M.

Breast Cancer Res. 2010;12(3):R31. doi: 10.1186/bcr2583. Epub 2010 Jun 2.

10.

Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.

Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, Gottesman MM, Varticovski L, Ambudkar SV.

J Natl Cancer Inst. 2010 Nov 3;102(21):1637-52. doi: 10.1093/jnci/djq361. Epub 2010 Oct 8.

11.

Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.

Uchino M, Kojima H, Wada K, Imada M, Onoda F, Satofuka H, Utsugi T, Murakami Y.

BMC Cancer. 2010 Aug 10;10:414. doi: 10.1186/1471-2407-10-414.

12.

SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.

Bhat-Nakshatri P, Appaiah H, Ballas C, Pick-Franke P, Goulet R Jr, Badve S, Srour EF, Nakshatri H.

BMC Cancer. 2010 Aug 6;10:411. doi: 10.1186/1471-2407-10-411.

13.

Impact of cell dissociation on identification of breast cancer stem cells.

Quan Y, Yan Y, Wang X, Fu Q, Wang W, Wu J, Yang G, Ren J, Wang Y.

Cancer Biomark. 2012-2013;12(3):125-33. doi: 10.3233/CBM-130300.

PMID:
23481571
14.

A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.

Lu M, Zhou L, Zheng X, Quan Y, Wang X, Zhou X, Ren J.

Cancer Biomark. 2015;15(2):163-70. doi: 10.3233/CBM-140450.

PMID:
25519016
15.

Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cells.

Montales MT, Rahal OM, Kang J, Rogers TJ, Prior RL, Wu X, Simmen RC.

Carcinogenesis. 2012 Mar;33(3):652-60. doi: 10.1093/carcin/bgr317. Epub 2012 Jan 4.

PMID:
22219179
16.

CD44(+)/CD24(-) cells are transit progenitors and do not determine the molecular subtypes and clinical parameters in breast carcinomas.

Lü X, Xu K, Lü H, Yin Y, Ma C, Liu Y, Li H, Suo Z.

Ultrastruct Pathol. 2011 Apr;35(2):72-8. doi: 10.3109/01913123.2010.544843.

PMID:
21299347
17.

[Analysis on clone in vitro and tumorigenic capacity in vivo of different subsets cells from the MCF-7 human breast cancer cell line].

Li Z, Liu CP, He YL, Tian Y, Huang T.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Jul;39(4):547-9. Chinese.

PMID:
18798490
18.

The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.

He M, Fu Y, Yan Y, Xiao Q, Wu H, Yao W, Zhao H, Zhao L, Jiang Q, Yu Z, Jin F, Mi X, Wang E, Cui Z, Fu L, Chen J, Wei M.

Clin Sci (Lond). 2015 Nov;129(9):809-22. doi: 10.1042/CS20140592. Epub 2015 Jul 2.

PMID:
26201092
19.

Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells.

Grimshaw MJ, Cooper L, Papazisis K, Coleman JA, Bohnenkamp HR, Chiapero-Stanke L, Taylor-Papadimitriou J, Burchell JM.

Breast Cancer Res. 2008;10(3):R52. doi: 10.1186/bcr2106. Epub 2008 Jun 9.

20.

Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.

Ahmadipour F, Noordin MI, Mohan S, Arya A, Paydar M, Looi CY, Keong YS, Siyamak EN, Fani S, Firoozi M, Yong CL, Sukari MA, Kamalidehghan B.

Drug Des Devel Ther. 2015 Feb 24;9:1193-208. doi: 10.2147/DDDT.S72127. eCollection 2015.

Supplemental Content

Support Center